Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00004330 · ClinicalTrials.gov registry record · NA
Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
A NA study, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
- NA
- Development phase
NCT00004330 is a NA study that has completed, run by National Center for Research Resources (NCRR).
The verdict
NCT00004330, a NA study, has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
OBJECTIVES: Assess whether chronic administration of gonadotropin-releasing hormone analogues is safe and effective for the prevention of cyclic attacks of acute porphyria in women.
Interventions
- DRUG luteinizing hormone-releasing factor
Trial Details
| Field | Value |
|---|---|
| Start Date | 1987-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00004330
The ClinicalTrials.gov registry entry for NCT00004330 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Center for Research Resources (NCRR), which has 94 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which luteinizing hormone-releasing factor is the first listed.
NCT00004330 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00004330 about?
NCT00004330 is a clinical study titled "Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks". OBJECTIVES: Assess whether chronic administration of gonadotropin-releasing hormone analogues is safe and effective for the prevention of cyclic attacks of acute porphyria in women.
What is the current status of trial NCT00004330?
This trial is currently completed. It is a NA study. The study started on 1987-03.
What interventions are being tested in trial NCT00004330?
The interventions under investigation include: luteinizing hormone-releasing factor (DRUG).
Who is sponsoring clinical trial NCT00004330?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.